Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Return on Sales (2016 - 2025)

Avricore Health has reported Return on Sales over the past 11 years, most recently at 0.13% for Q4 2025.

  • Quarterly Return on Sales fell 13.0% to 0.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, down 3.0% year-over-year, with the annual reading at 0.03% for FY2025, 3.0% down from the prior year.
  • Return on Sales was 0.13% for Q4 2025 at Avricore Health, down from 0.1% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q1 2023 and troughed at 0.25% in Q2 2021.
  • The 5-year median for Return on Sales is 0.0% (2022), against an average of 0.04%.
  • Year-over-year, Return on Sales rose 24bps in 2022 and then decreased -16bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then soared by 79bps to 0.0% in 2022, then skyrocketed by 121bps to 0.0% in 2023, then increased by 27bps to 0.0% in 2024, then tumbled by -20673bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Return on Sales are 0.13% (Q4 2025), 0.1% (Q3 2025), and 0.16% (Q2 2025).